Literature DB >> 2807275

Tissue specificity of chromosomal rearrangements in ataxia-telangiectasia.

T L Kojis1, R R Schreck, R A Gatti, R S Sparkes.   

Abstract

Cytogenetic studies of lymphocytes and fibroblasts from individuals with ataxia-telangiectasia (AT) demonstrate spontaneous chromosomal breakage. In the AT lymphocytes, this damage results in a high frequency of balanced rearrangements involving chromosome bands 7p14, 7q35, 14q12, and 14q32. The T-cell receptor alpha, beta, and gamma chain gene complexes and the immunoglobulin heavy chain gene complex, all of which may be functional in lymphocytes, have been localized to these bands. To assess the relationship between genes at these breakpoints and the entirety of the AT phenotype, we undertook a detailed cytogenetic analysis of fibroblasts and lymphocytes from seven AT homozygotes. Our findings indicate that the rearrangements present in the lymphocytes are not commonly observed in the fibroblasts, despite the increased instability of chromosomes from the cells relative to lymphocytes. Furthermore, the changes in the fibroblasts are neither consistent within nor between patients, suggesting that chromosome rearrangement occurs more randomly in this tissue. Therefore, differential site-specific damage in separate tissue may generate the distinct features of the disease in those tissues and may account for the pleiotrophic effects of the AT gene.

Entities:  

Mesh:

Year:  1989        PMID: 2807275     DOI: 10.1007/bf00291379

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Location of gene for beta subunit of human T-cell receptor at band 7q35, a region prone to rearrangements in T cells.

Authors:  M Isobe; J Erikson; B S Emanuel; P C Nowell; C M Croce
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

2.  Non-random in vitro 7;14 translocations detected in a routine cytogenetic series. 12 examples and their possible significance.

Authors:  C Wallace; R Bernstein; M R Pinto
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Chromosomal localization of the human T cell receptor beta-chain genes.

Authors:  M M Le Beau; M O Diaz; J D Rowley; T W Mak
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

4.  A recurrent structural aberration, t(7;14), in phytohemagglutinin-stimulated lymphocytes.

Authors:  L Zech; U Haglund
Journal:  Hereditas       Date:  1978       Impact factor: 3.271

5.  High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia.

Authors:  A Aurias; B Dutrillaux; D Buriot; J Lejeune
Journal:  Mutat Res       Date:  1980-02       Impact factor: 2.433

6.  Evolution of chromosomal abnormalities in sequential cytogenetic studies of ataxia telangiectasia.

Authors:  A Al Saadi; M Palutke; G K Kumar
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci.

Authors:  C T Denny; Y Yoshikai; T W Mak; S D Smith; G F Hollis; I R Kirsch
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

8.  Constitutive fragile sites and cancer.

Authors:  J J Yunis; A L Soreng
Journal:  Science       Date:  1984-12-07       Impact factor: 47.728

9.  Chromosomal abnormalities in ataxia-telangiectasia (Louis Bar's syndrome).

Authors:  R A Pfeiffer
Journal:  Humangenetik       Date:  1970

10.  Genes for beta chain of human T-cell antigen receptor map to regions of chromosomal rearrangement in T cells.

Authors:  C C Morton; A D Duby; R L Eddy; T B Shows; J G Seidman
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

View more
  9 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  A variant of the Nijmegen breakage syndrome with unusual cytogenetic features and intermediate cellular radiosensitivity.

Authors:  R Tupler; G L Marseglia; M Stefanini; E Prosperi; L Chessa; T Nardo; A Marchi; P Maraschio
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  Fine mapping of the chromosome 11q22-23 region using PFGE, linkage and haplotype analysis; localization of the gene for ataxia telangiectasia to a 5cM region flanked by NCAM/DRD2 and STMY/CJ52.75, phi 2.22.

Authors:  C M McConville; C J Formstone; D Hernandez; J Thick; A M Taylor
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

4.  Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies.

Authors:  S Lipkowitz; V F Garry; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Recombination and its roles in DNA repair, cellular immortalization and cancer.

Authors:  M A Shammas; R J Shmookler Reis
Journal:  Age (Omaha)       Date:  1999-04

6.  Cytogenetic investigations in three cell types of a Saudi family with ataxia telangiectasia.

Authors:  M Waghray; G G Gascon; S al-Sedairy; M A Hannan
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

7.  The atm-1 gene is required for genome stability in Caenorhabditis elegans.

Authors:  Martin R Jones; Jim Chin Huang; Shu Yi Chua; David L Baillie; Ann M Rose
Journal:  Mol Genet Genomics       Date:  2012-02-18       Impact factor: 3.291

8.  Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes.

Authors:  S Lipkowitz; M H Stern; I R Kirsch
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

9.  The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage.

Authors:  K D Brown; Y Ziv; S N Sadanandan; L Chessa; F S Collins; Y Shiloh; D A Tagle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.